- Corporate Officers - C
- Cox Carrie Smith
Insider Trading History of Cox Carrie Smith
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cox Carrie Smith since 2015.
This trader's CIK number is 1110753.
At the time of last reporting, Cox Carrie Smith was the Executive Chair of Organon & Co.. (stock ticker symbol OGN).
Also see all insider trading activities at Organon & Co..
Note that in the past
COX CARRIE SMITH also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Electrocore, Inc. (ECOR) by Cox Carrie Smith
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ECOR | 10,000 | $18,200 | 0 | $0 | 0 | $0 |
| 2018 | ECOR | 11,000 | $100,478 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cartesian Therapeutics, Inc. (SELB) by Cox Carrie Smith
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | SELB | 130,000 | $149,760 | 0 | $0 | 0 | $0 |
| 2021 | SELB | 17,200 | $50,671 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Texas Instruments Inc (TXN) by Cox Carrie Smith
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | TXN | 0 | $0 | 16,055 | $2,890,542 | 16,055 | $1,061,155 |
| 2020 | TXN | 0 | $0 | 49,743 | $6,907,637 | 49,743 | $1,995,968 |
| 2019 | TXN | 0 | $0 | 17,002 | $1,973,575 | 17,002 | $490,337 |
| 2017 | TXN | 0 | $0 | 14,000 | $1,151,500 | 14,000 | $313,180 |
| 2015 | TXN | 0 | $0 | 22,000 | $1,100,000 | 22,000 | $669,570 |
Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Cox Carrie Smith
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ARRY | 5,000 | $116,000 | 0 | $0 | 0 | $0 |
| 2018 | ARRY | 3,000 | $50,594 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Celgene Corp /de/ (CELG) by Cox Carrie Smith
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CELG | 0 | $0 | 0 | $0 | 12,500 | $323,625 |
| 2018 | CELG | 0 | $0 | 0 | $0 | 6,200 | $0 |
| 2017 | CELG | 0 | $0 | 0 | $0 | 734 | $0 |
| 2016 | CELG | 0 | $0 | 0 | $0 | 6,933 | $0 |
| 2015 | CELG | 0 | $0 | 0 | $0 | 2,783 | $0 |
Yearly summary of insider trading at Solventum Corp (SOLV) by Cox Carrie Smith
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | SOLV | 0 | $0 | 0 | $0 | 5,148 | $0 |
Yearly summary of insider trading at Organon & Co. (OGN) by Cox Carrie Smith
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | OGN | 65,400 | $501,748 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Cox Carrie Smith:
1. Electrocore, Inc. (ECOR)
2. Cartesian Therapeutics, Inc. (SELB)
3. Texas Instruments Inc (TXN)
4. Array Biopharma Inc (ARRY)
5. Celgene Corp /de/ (CELG)
6. Solventum Corp (SOLV)
7. Organon & Co. (OGN)
Table 1. Insider trading of Electrocore, Inc. (ECOR) by Cox Carrie Smith
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-06 | ECOR | Buy | 10,000 | 1.82 | 18,200 |
| 2018-12-03 | ECOR | Buy | 7,300 | 6.79 | 49,559 |
| 2018-08-17 | ECOR | Buy | 3,700 | 13.76 | 50,919 |
Table 2. Insider trading of Cartesian Therapeutics, Inc. (SELB) by Cox Carrie Smith
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-13 | SELB | Buy | 130,000 | 1.15 | 149,760 |
| 2021-12-03 | SELB | Buy | 17,200 | 2.95 | 50,671 |
Table 3. Insider trading of Texas Instruments Inc (TXN) by Cox Carrie Smith
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-31 | TXN | Option Ex | 16,055 | 66.09 | 1,061,155 |
| 2023-07-31 | TXN | Sale | 16,055 | 180.04 | 2,890,542 |
| 2020-10-23 | TXN | Sale | 22,838 | 149.31 | 3,409,987 |
| 2020-10-23 | TXN | Option Ex | 22,838 | 49.02 | 1,119,404 |
| 2020-07-24 | TXN | Option Ex | 26,905 | 32.58 | 876,564 |
| 2020-07-24 | TXN | Sale | 26,905 | 130.00 | 3,497,650 |
| 2019-04-29 | TXN | Option Ex | 17,002 | 28.84 | 490,337 |
| 2019-04-29 | TXN | Sale | 17,002 | 116.08 | 1,973,575 |
| 2017-07-27 | TXN | Option Ex | 14,000 | 22.37 | 313,180 |
| 2017-07-27 | TXN | Sale | 14,000 | 82.25 | 1,151,500 |
| 2015-07-28 | TXN | Option Ex | 22,000 | 30.43 | 669,570 |
| 2015-07-28 | TXN | Sale | 22,000 | 50.00 | 1,100,000 |
Table 4. Insider trading of Array Biopharma Inc (ARRY) by Cox Carrie Smith
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-19 | ARRY | Buy | 5,000 | 23.20 | 116,000 |
| 2018-11-01 | ARRY | Buy | 3,000 | 16.86 | 50,594 |
Table 5. Insider trading of Celgene Corp /de/ (CELG) by Cox Carrie Smith
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-10-29 | CELG | Option Ex | 12,500 | 25.89 | 323,625 |
| 2018-06-12 | CELG | Option Ex | 6,200 | .00 | 0 |
| 2017-07-01 | CELG | Option Ex | 734 | .00 | 0 |
| 2016-07-01 | CELG | Option Ex | 733 | .00 | 0 |
| 2016-06-16 | CELG | Option Ex | 6,200 | .00 | 0 |
| 2015-07-01 | CELG | Option Ex | 733 | .00 | 0 |
| 2015-06-16 | CELG | Option Ex | 2,050 | .00 | 0 |
Table 6. Insider trading of Solventum Corp (SOLV) by Cox Carrie Smith
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-13 | SOLV | Option Ex | 5,148 | .00 | 0 |
Table 7. Insider trading of Organon & Co. (OGN) by Cox Carrie Smith
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-11-12 | OGN | Buy | 65,400 | 7.67 | 501,748 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cox Carrie Smith
(Executive Chair of Organon & Co. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.